Compare Cintas Corporation (CTAS) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cintas Corporation vs Citius Pharmaceuticals Inc — how do they compare? Cintas Corporation trades at $205.28 (market cap $82.15B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Cintas Corporation is far larger — about 4105.4× Citius Pharmaceuticals Inc's market cap, and Cintas Corporation pays a 1.01% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CTAS | CTXR | |
|---|---|---|
Market Cap | $82.15B | $20.01M |
Sector | Industrials | Health |
52-Week High | $225.10 | $1.82 |
52-Week Low | $163.55 | $0.48 |
Enterprise Value | $84.56B | $16.23M |
Dividend Yield | 1.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
